This is Thomas Sullivan - Policy & Medicine Writing Staff's Typepad Profile.
Join Typepad and start following Thomas Sullivan - Policy & Medicine Writing Staff's activity
Join Now!
Already a member? Sign In
Thomas Sullivan - Policy & Medicine Writing Staff
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
The American Medical Informatics Association (AMIA) responded to a request for information (RFI) issued by the Office of the National Coordinator for Health IT (ONC) outlining a draft framework to measure the use of interoperability standards in health IT products.... Continue reading
Posted 16 hours ago at Policy and Medicine
Image
A recent Centers for Medicare & Medicaid Services (CMS) proposed rule would ease EHR reporting requirements over the next two years. The proposed regulation, which covers the 2018 Medicare payments for hospital inpatient services, relaxes data reporting requirements for Clinical... Continue reading
Posted 3 days ago at Policy and Medicine
Image
We have previously written about the ballot proposition that is scheduled to be on the ballot in Ohio this November as Issue #2. – An analysis by former Ohio Budget Director Greg Browning has found that a key claim by... Continue reading
Posted 4 days ago at Policy and Medicine
Image
Last month, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes proposals to update payment policies, payment rates, and quality provisions for services furnished under the Medicare Physician Fee Schedule (PFS) on or after January... Continue reading
Posted 5 days ago at Policy and Medicine
Image
Working off of the recent recommendations in the interim report issued by the President’s Commission on Combating Drug Addiction and the Opioid Crisis, President Donald Trump has issued a directive to his administration to use all “appropriate emergency and other... Continue reading
Posted 6 days ago at Policy and Medicine
Image
In early 2017, South Korea joined the global transparency movement and enacted a “Sunshine Act” similar to others found around the world. The law requires pharmaceutical and medical device companies operating in South Korea to prepare an aggregated expenditure report... Continue reading
Posted 7 days ago at Policy and Medicine
Image
In the 2018 proposed Medicare Fee Schedule rule, CMS reviews MACRA patient relationship categories and codes, their development and timelines, and provides details for the initial claims-based reporting of the relationship categories and codes to CMS. Background Section 101(f) of... Continue reading
Posted Aug 11, 2017 at Policy and Medicine
Image
As we recently reported, CMS published their proposed rule to update the MACRA Quality Payment Program (QPP). The QPP is a part of a fundamental shift from fee-for-service to a more value-based health care system. Below, we offer a more... Continue reading
Posted Aug 10, 2017 at Policy and Medicine
Image
In June 2017, the Court of Justice of the European Union ruled that courts may consider vaccines to be the cause of an illness, even if there is no scientific evidence confirming a link. The Court said that if the... Continue reading
Posted Aug 9, 2017 at Policy and Medicine
Image
Last month, the FDA issued two proposed studies on disclosures for advertising: one for general advertising and another for oncology advertising. Both studies have comment periods that end on August 18, 2017. For both proposals, FDA invites comments on these... Continue reading
Posted Aug 8, 2017 at Policy and Medicine
Image
In July 2017, a Chicago jury found AbbVie Inc. guilty of fraudulently misrepresenting the risks of its testosterone replacement drug AndroGel. The federal jury ordered the company to pay $150 million in punitive damages. Allegations The verdict comes in a... Continue reading
Posted Aug 7, 2017 at Policy and Medicine
Image
United States Senator Claire McCaskill recently announced that she is expanding her wide-ranging investigation into the causes of the current opioid epidemic by requesting information and documents from four additional pharmaceutical manufacturers and three opioid distributors. Her requests focus on... Continue reading
Posted Aug 7, 2017 at Policy and Medicine
Image
After many months of debate, both chambers of Congress passed the FDA User Fee Package. This comes after the Senate passed its bill (S. 934) which cleared the Senate HELP Committee in May on a bipartisan basis. The House passed... Continue reading
Posted Aug 3, 2017 at Policy and Medicine
Image
Celgene Corporation has settled a whistleblower lawsuit for $280 million, alleging that the pharmaceutical company committed fraud promoting Thalomid, a cancer drug allegedly promoted for uses not approved by the United States Food and Drug Administration (FDA). The settlement will... Continue reading
Posted Aug 3, 2017 at Policy and Medicine
Image
The White House’s Commission on Combating Drug Addiction and the Opioid Crisis (Opioid Commission) has issued an interim report, which offers recommended actions for President Trump to take now, with more recommendations planned for the fall of 2017. The headline-creator... Continue reading
Posted Aug 2, 2017 at Policy and Medicine
Image
Mallinckrodt and the Federal Trade Commission (FTC) recently agreed to settle allegations of raising drug prices and engaging in anti-competitive practices by paying a $100 million fine and allowing a competitor to produce a similar medication. The drug, H.P. Acthar... Continue reading
Posted Aug 1, 2017 at Policy and Medicine
Image
We recently wrote about ten Canadian pharmaceutical companies that are voluntarily disclosing payment amounts to the general public. Now, the Ontario Health Minister, Eric Hoskins, is thinking about mandating that pharmaceutical companies disclose payments made to doctors. He made the... Continue reading
Posted Jul 31, 2017 at Policy and Medicine
Image
In a much-anticipated U.S. Court of Appeals decision, the Fourth Circuit on February 14, 2017, in evaluating the issue of whether the government has veto power over False Claims Act (FCA) settlements, particularly where liability is established by use of... Continue reading
Posted Jul 31, 2017 at Policy and Medicine
Image
In late June 2017, the U.S. Food and Drug Administration (“FDA”) unveiled a strategic plan to both eliminate the agency’s existing orphan designation request backlog and ensure timely responses to all new requests for designation with firm deadlines. This Orphan... Continue reading
Posted Jul 28, 2017 at Policy and Medicine
Image
Pharmaceutical and medical device manufacturers continue to face intense scrutiny from regulatory and enforcement agencies, as well as whistleblowers seeking large payouts for disclosing potential wrongdoing. There are a number of risk areas (some new, some not-so-new) that provide the... Continue reading
Posted Jul 28, 2017 at Policy and Medicine
Image
Ten well-known drug companies in Canada have started to voluntarily disclose how much money they pay to physicians, hospitals, and health care groups, with the information posted on their websites. The ten companies participating in the voluntary disclosure are: GlaxoSmithKline,... Continue reading
Posted Jul 27, 2017 at Policy and Medicine
Image
Over three years ago, the Toronto Star filed a freedom of information (FIPPA) request with the Health Ministry in Ontario, Canada, seeking physician-identified data on the top 100 billers. Last year, the information and privacy commissioner ordered the disclosure of... Continue reading
Posted Jul 26, 2017 at Policy and Medicine
Image
Part 2: The Tension Increases - Online Auctions Violate the AKS We have noted in previous articles that there is an increasing tension between efforts to reduce healthcare costs and assuring those efforts are not improper inducements under the Anti-Kickback... Continue reading
Posted Jul 26, 2017 at Policy and Medicine
Image
The National Academies of Sciences, Engineering, and Medicine recently released a report, requested by the United States Food and Drug Administration, that highlights what can be done to stop the opioid use disorder and other opioid-related harms without closing access... Continue reading
Posted Jul 25, 2017 at Policy and Medicine
Image
Earlier this month, the American Academy of Family Physicians (AAFP) announced a collaboration with the American Board of Family Medicine (ABFM) to create a more seamless credit-reporting experience for family physicians. The new process will allow AAFP members to use... Continue reading
Posted Jul 24, 2017 at Policy and Medicine